S&P 500   2,998.64 (+0.30%)
DOW   27,022.90 (+0.08%)
QQQ   193.41 (+0.19%)
AAPL   234.33 (-0.02%)
FB   189.67 (+0.06%)
MSFT   139.47 (-0.67%)
AMZN   1,790.38 (+0.73%)
NVDA   192.60 (-0.83%)
MU   45.44 (+0.62%)
BABA   176.24 (-0.50%)
GE   9.07 (+1.80%)
TSLA   262.42 (+1.03%)
AMD   31.02 (+0.68%)
F   9.10 (+0.33%)
ACB   3.80 (+5.27%)
NFLX   296.10 (+3.43%)
GILD   65.16 (-0.29%)
DIS   132.86 (+1.53%)
S&P 500   2,998.64 (+0.30%)
DOW   27,022.90 (+0.08%)
QQQ   193.41 (+0.19%)
AAPL   234.33 (-0.02%)
FB   189.67 (+0.06%)
MSFT   139.47 (-0.67%)
AMZN   1,790.38 (+0.73%)
NVDA   192.60 (-0.83%)
MU   45.44 (+0.62%)
BABA   176.24 (-0.50%)
GE   9.07 (+1.80%)
TSLA   262.42 (+1.03%)
AMD   31.02 (+0.68%)
F   9.10 (+0.33%)
ACB   3.80 (+5.27%)
NFLX   296.10 (+3.43%)
GILD   65.16 (-0.29%)
DIS   132.86 (+1.53%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Geovax LabsALGAE TEC LTD/SRedpoint BioProtalexUS Stem Cell
SymbolOTCMKTS:GOVXOTCMKTS:ALGXYN/AOTCMKTS:PRTXOTCMKTS:USRM
Price Information
Current Price$0.00$0.00N/A$0.02$0.01
52 Week RangeN/AN/AN/AN/AN/A
Analyst Ratings
Consensus RecommendationN/AN/AN/AN/AN/A
Consensus Price TargetN/AN/AN/AN/AN/A
% Upside from Price TargetN/AN/AN/AN/AN/A
Trade Information
Market Cap$153,000.00N/AN/A$710,000.00$2.19 million
Beta0.4557.13N/A-1.255.03
Average Volume31,235,964273N/A8,309792,673
Sales & Book Value
Annual Revenue$960,000.00$2.05 millionN/AN/A$6.70 million
Price / Sales0.16N/AN/AN/A0.33
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value($6.84) per share$0.10 per shareN/A($0.04) per share($0.02) per share
Price / Book0.00N/AN/AN/A-0.28
Profitability
Net Income$-2,560,000.00$-6,080,000.00N/A$-5,030,000.00$-2,160,000.00
EPS($10.00)N/AN/AN/AN/A
Trailing P/E RatioN/A0.000.000.000.00
Forward P/E RatioN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-217.43%N/AN/AN/A-39.64%
Return on Equity (ROE)N/AN/AN/AN/AN/A
Return on Assets (ROA)-511.26%N/AN/AN/A-152.37%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/AN/AN/AN/A
Current Ratio0.20%N/AN/AN/A0.09%
Quick Ratio0.20%N/AN/AN/A0.08%
Ownership Information
Institutional Ownership PercentageN/AN/AN/A0.23%N/A
Insider Ownership Percentage3.00%N/A11.51%80.00%16.72%
Miscellaneous
Employees8N/AN/A210
Shares Outstanding95.63 millionN/AN/A47.33 million397.74 million
Next Earnings Date11/14/2019 (Estimated)N/AN/A10/18/2019 (Estimated)11/6/2019 (Estimated)
OptionableNot OptionableNot OptionableNot OptionableNot OptionableNot Optionable
 Geovax LabsALGAE TEC LTD/SRedpoint BioProtalexUS Stem Cell

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel